Point-of-Care Ultrasound in Aged Care: The Diagnostic Layer Asia-Pacific Cannot Afford to Skip
7/29/20265 min read
Asia-Pacific's aged care systems are under a kind of pressure that does not show up cleanly in a budget line. It shows up as a resident who becomes confused overnight, a nurse who cannot get a clear read on whether breathlessness is cardiac or pulmonary, or a care home that must decide, at 2am and without a doctor on site, whether a transfer to hospital is necessary.
China's population aged 65 and above now exceeds 220 million. Singapore will become a "super-aged" society within this decade. The UK's aged care sector is managing longer lengths of stay with tighter clinical staffing. In each of these markets, the same operational question keeps recurring: what diagnostic capability should sit closer to the resident, rather than several hours or one ambulance ride away?
Point-of-care ultrasound (POCUS) is one answer that is no longer theoretical.
A gap that shows up at the bedside, not in the imaging suite
A resident in a nursing home becomes agitated and stops eating. Is this a urinary tract infection, urinary retention, or early delirium from something else entirely? A patient recovering from a fall has new leg swelling. Is it venous, or is it simply positional? A frail 84-year-old with COPD reports worsening breathlessness overnight: is there pleural fluid that changes the urgency of the decision?
In a hospital, these questions are answered by sending the patient to radiology. In a residential aged care facility, or in a lower-resourced hospital ward without 24-hour imaging access, that pathway often means an ambulance, an emergency department wait, and, for a frail elderly patient, a transfer that carries its own clinical risk.
This is the gap that portable ultrasound is built to narrow. Not by replacing formal imaging, but by giving frontline clinicians and trained nursing staff a focused visual answer to a specific question, at the moment the question is being asked.
The evidence base is no longer anecdotal
The clinical literature on this shift has moved past pilot studies. A 2025 review of point-of-care ultrasound use among emergency department palliative care patients (median age 71) found that POCUS examinations were documented in roughly half of all palliative encounters, most often to answer a single, focused question: is there fluid, is there obstruction, is there a finding that changes the plan of care right now.
That pattern, a narrow question answered quickly at the bedside, is precisely what makes POCUS suited to aged care, where the clinical picture in older adults is frequently atypical. Infection often presents without fever. Retention often presents as confusion. A stethoscope and a set of vital signs can miss what a thirty-second focused scan will not.
Training infrastructure is catching up to demand. In 2026, Johns Hopkins School of Nursing introduced what it describes as the first advanced-practice nursing curriculum built specifically around point-of-care ultrasound, a signal that this capability is being formalised as a nursing competency, not held back as a physician-only, radiology-adjacent skill.
The market signal behind the clinical case
Clinical merit alone does not drive institutional procurement; adoption also has to make commercial sense at scale. On that front, the regional numbers are unambiguous.
The Asia-Pacific point-of-care ultrasound market is projected to grow at a compound annual rate of 14.4% through 2030, with the region expected to hold roughly 28.3% of global market share by 2025, among the fastest-growing geographies worldwide. The drivers cited across market analyses are consistent with what aged care operators already know on the ground: an accelerating elderly population in China, Japan and South Korea; rising healthcare expenditure; and a cost structure that makes portable ultrasound achievable for facilities that could never justify a fixed radiology suite.
For a hospital or aged care network with sites across Singapore, China and the UK, that growth curve is not simply a market forecast to note in passing. It is a signal that the vendor landscape, the training ecosystem and the regulatory pathways for this category are maturing quickly, and that institutions who wait risk adopting the technology later, on someone else's terms, once standards have already been set.
An extension of clinical judgement, not a substitute for radiology
The most common misstep in evaluating this category is asking whether portable ultrasound can replace formal diagnostic imaging. In an aged care or general ward setting, it should not, and it is not designed to.
Formal ultrasound performed by a trained sonographer, with full protocol coverage and specialist reporting, remains the standard for definitive diagnosis. Point-of-care ultrasound answers a different, narrower category of question, in real time, at the point where the clinical decision is actually being made: is this bladder retention or something else; is there pleural fluid that changes today's escalation decision; is this soft-tissue swelling a straightforward cellulitis or does it need urgent review.
A nurse checking bladder volume before considering catheterisation is not performing a urology scan. A care coordinator using a focused scan to inform an escalation decision at a nursing home is not replacing a radiologist. Positioned correctly, portable ultrasound adds a visual layer to the clinical reasoning that is already happening; it does not attempt to sit above it.
Why the cross-border dimension matters for procurement
Institutions weighing this technology across Singapore, China and the UK are not evaluating a single, uniform market. Regulatory approval pathways differ. Manufacturer documentation (CE marking, FDA 510(k) status, ISO certification) needs to be verified against each jurisdiction's requirements. Training and governance expectations for nursing-led ultrasound use are not identical across these three health systems, and procurement teams operating across borders often find that the technical specification of a device is the easy part of the decision; the harder part is confirming it can be deployed compliantly, trained consistently, and supported clinically across every site in the network.
This is precisely where cross-border implementation experience earns its value, not in sourcing a device, but in navigating the regulatory and governance layer around it: verifying manufacturer technical files, aligning training curricula with local scope-of-practice rules, and ensuring that what works in a Singapore nursing home is deployed with the same rigour in a UK care facility or a hospital ward in China.
Governance has to scale with the technology
Portable does not mean casual. Ultrasound remains operator-dependent: poor image acquisition can mislead, overconfident interpretation can delay an appropriate referral, and an incidental finding handled without a clear escalation pathway can create more uncertainty than it resolves.
A credible aged care or hospital deployment needs, at minimum: defined clinical indications and user groups, structured training with documented competency assessment, standard scanning protocols, clear escalation pathways when a finding requires further review, and alignment with each jurisdiction's clinical governance and regulatory requirements. The device is genuinely portable. The oversight around it cannot be.
What this means for institutional buyers this year
For hospital and aged care procurement teams evaluating diagnostic investments in the year ahead, the point-of-care ultrasound category has crossed from emerging to established: a 14.4% regional growth rate, a maturing training pipeline, and clinical evidence specific to older patient populations all point in the same direction.
The institutions likely to benefit most are not necessarily the earliest adopters of any single device, but those that pair the technology with the governance, training and cross-border regulatory diligence needed to deploy it safely and consistently across every site they operate.
Vitania works with hospital and aged care networks across Singapore, China and the UK to evaluate portable diagnostic technologies against exactly this standard: clinical fit, regulatory pathway, and training infrastructure, not device specifications in isolation. If your organisation is assessing point-of-care ultrasound as part of its next diagnostic investment cycle, we would be glad to share what we are seeing across these three markets.
References and Source Materials
- Applications and indications of point-of-care ultrasound in emergency department encounters involving palliative care patients, PMC (2025)
- The rise of point-of-care ultrasound in cardiopulmonary diagnostics, PMC
- Asia Pacific Point-of-Care Ultrasound Market Size & Trends, Research and Markets
- Point of Care Ultrasound Market Size Report, 2026–2035, Global Market Insights
- Global Portable Ultrasound Market to Reach USD 3.83 Billion by 2030, MarketsandMarkets, via GlobeNewswire (April 2026)
- Now You See It: POCUS Changes the Diagnostic Game, Johns Hopkins School of Nursing (May 2026)
- United Nations population ageing data, China and Singapore national statistics offices
✉️ Email Address:
📍Singapore Headquarters:
14, Robinson Road, #08-01A
Far East Finance Building
Singapore 048545
📍United Kingdom Office:
71–75 Shelton Street
London, WC2H 9JQ
United Kingdom